Year: 2013
Type: dissertation
Study design: Clinical Trial
Abstract: Salbutamol is a β2 adrenergic agonist widely used for the treatment of asthma and known to reduce plasma potassium concentration [K+]. The International Olympic Committee had been concerned that salbutamol may give an inequitable advantage to athletes. However, little work has investigated whether salbutamol has beneficial effects on plasma [K+], K+ dynamics during exercise and how these potential changes may impact on exercise performance. This study investigated the effects of salbutamol on K+ regulation at rest, during and following submaximal and high intensity continuous exercise, as well as during and following repeat sprint exercise. The impact on performance during repeat sprint exercise was also explored. Seven healthy, recreationally-active men (age 23.29 ± 5.96 yr, height 178.03 ± 9.06 cm, body mass 72.23 ± 8.47 kg, mean ±SD) participated in the study which utilised a double-blind, randomised crossover design, with two trials separated by two weeks. Participants received either 1000 µg of salbutamol or a placebo via inhalation, 30 min prior to performing continuous cycle ergometer exercise comprising 5 min at 40 % V
Author: Muath M. Altarawneh
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1917794792
